The CBSE Class 12 Mathematics exam has been concluded, and students’ reactions along with a detailed paper analysis are now live. Initial responses suggest that the paper was balanced and largely in ...
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...
Welcome to the SuRo Capital's Fourth Quarter and Fiscal Year 2025 Earnings Call. My name is Alan, and I will be your coordinator for today's event. Please note, this call is being recorded. [Operator ...
loanDepot, Inc. ( LDI) Q4 2025 Earnings Call March 10, 2026 5:00 PM EDT Good afternoon, everyone, and welcome to loanDepot's Year-end and Fourth Quarter 2025 Earnings Call. [Operator Instructions] ...
Earnings call loanDepot's Q4 2025 saw origination volume jump 23% sequentially to $8.0B, the highest since 2022, with market share gains and a 71% recapture rate. Despite this, adjusted net loss ...
Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained ...
FuelCell Energy, Inc. (NASDAQ:FCEL) Q1 2026 Earnings Call Transcript March 9, 2026 FuelCell Energy, Inc. beats earnings expectations. Reported EPS is $-0.49081, expectations were $-0.68. Operator: ...
A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...
13d
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...
Microsoft Math Solver is a free tool that uses AI to recognize both printed and handwritten math. It’s particularly strong with geometric proofs and interactive graphing, and it pulls learning ...
The result in our view is a new vision where distributed, “mini AI factories” operate (often indoors) at the enterprise edge. We believe this demands an entirely new platform model that we call it the ...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results